Medicare Enrolled

Dr. Jeffrey Gelblum, MD

Neurology · Aventura, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
2801 NE 213TH ST STE 1004, Aventura, FL 33180
3059369393
In practice since 2006 (19 years)
NPI: 1124057898 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gelblum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gelblum? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gelblum

Dr. Jeffrey Gelblum is a neurology in Aventura, FL, with 19 years in practice. Based on federal Medicare data, Dr. Gelblum performed 14,024 Medicare services across 1,552 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gelblum received a total of $229,618 from 54 pharmaceutical and/or device companies across 707 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gelblum is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 7% volume in FL$ $229,618 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,024
Medicare services
Top 7% in FL for neurology
1,552
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~738 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit11,600$5$24
Office visit, established patient, complex (40-54 min)631$135$788
Office visit, established patient (30-39 min)624$79$562
EEG, extended monitoring141$365$1,914
Measurement of nerve conduction using visual stimulation testing with report140$55$285
Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report138$71$366
New patient office visit, complex (60-74 min)125$175$976
Needle measurement of electrical activity in arm or leg muscles, complete study115$81$439
Limited ultrasound scan of joint or other extremity structure except blood vessels107$36$241
Placement of skin electrodes and measurement of stimulated sites in arms102$149$730
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes76$230$1,021
Testing of autonomic (sympathetic) nervous system function52$103$1,114
Nerve conduction, 11-12 studies48$207$1,116
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face36$152$772
Placement of skin electrodes and measurement of stimulated sites in legs36$130$615
Annual depression screening34$19$77
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box19$200$1,220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$229,618
Total received (2018-2024)
Avg $32,803/year across 7 years
Top 3% in FL for neurology
54
Companies
707
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$175,599 (76.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$44,257 (19.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,763 (4.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$94,149
2023
$72,744
2022
$39,092
2021
$2,182
2020
$344
2019
$14,653
2018
$6,454

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$81,817
Corium, LLC
$42,304
Alnylam Pharmaceuticals Inc.
$27,853
Biogen, Inc.
$19,734
Lilly USA, LLC
$18,139
Akcea Therapeutics, Inc.
$13,866
Otsuka America Pharmaceutical, Inc.
$6,399
Avanir Pharmaceuticals, Inc.
$6,115
AstraZeneca Pharmaceuticals LP
$4,197
ABBVIE INC.
$1,391
Dr.Reddy's Laboratories,Inc.
$799
Alexion Pharmaceuticals, Inc.
$734
Neurocrine Biosciences, Inc.
$619
Abbott Laboratories
$518
Teva Pharmaceuticals USA, Inc.
$507
Amgen Inc.
$337
Allergan, Inc.
$328
UCB, Inc.
$326
ARGENX US, INC.
$317
PFIZER INC.
$304
Novartis Pharmaceuticals Corporation
$288
Lundbeck LLC
$248
Life Molecular Imaging Ltd
$235
Greenwich Biosciences, Inc.
$233
Merz Pharmaceuticals, LLC
$195
ANI Pharmaceuticals, Inc.
$173
Amneal Pharmaceuticals LLC
$150
Allergan Inc.
$135
REVANCE THERAPEUTICS, INC.
$125
AbbVie Inc.
$124
JAZZ PHARMACEUTICALS INC.
$122
Eli Lilly and Company
$118
Takeda Pharmaceuticals U.S.A., Inc.
$92
ACADIA Pharmaceuticals Inc
$81
MITSUBISHI TANABE PHARMA AMERICA, INC.
$77
US WorldMeds, LLC
$61
Averitas Pharma Inc.
$60
Kyowa Kirin, Inc.
$56
SK Life Science, Inc.
$45
Biohaven Pharmaceuticals, Inc.
$43
LivaNova USA, Inc.
$39
Avion Pharmaceuticals
$36
Sumitomo Pharma America, Inc.
$29
Brainsway USA INC
$28
GRT US Holding, Inc.
$26
Biohaven Pharmaceutical Holding Company Ltd.
$26
Aucta Pharmaceuticals, Inc.
$25
Grifols USA, LLC
$24
Bausch Health US, LLC
$24
Mitsubishi Tanabe Pharma America, Inc.
$23
Acorda Therapeutics, Inc
$21
Alfasigma USA, Inc.
$19
ARBOR PHARMACEUTICALS, INC.
$18
CSL Behring
$15
Top 3 companies account for 66.2% of total payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APTIOM · AUSTEDO · AVONEX · AZSTARYS · Adlarity · Aimovig · Austedo XR · Azstarys · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Brainsway Deep TMS · Briviact · COMIRNATY · CONFIRM RX · DAXXIFY · Dhivy · EMGALITY · EPIDIOLEX · ETERNA · Epidiolex · Fycompa · GAMMAGARD · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · Leqembi · MAYZENT · MIGRANAL · MYOBLOC · Motpoly XR · NEURACEQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA Xsail · Ongentys · PANZYGA · PAXLOVID · PROCLAIM · PURIFIED CORTROPHIN GEL · QULIPTA · QUTENZA · Qutenza · RADICAVA · REXULTI · RYTARY · Radicava · Rystiggo · SKYCLARYS · SOLIRIS · Soliris · TEGSEDI · UBRELVY · ULTOMIRIS · UPLIZNA · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · Xeomin · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in FL.

Equivalent to $1,637 per 100 Medicare services performed
Looking for a neurology in Aventura?
Compare neurologys in the Aventura area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
297
Per 100K population
11.1
County median income
$68,694
Nearest hospital
HCA FLORIDA AVENTURA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gelblum is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), and high industry engagement (speaking/promotional, top 3%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gelblum experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Gelblum performed 11,600 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gelblum receive payments from pharmaceutical companies?
Yes. Dr. Gelblum received a total of $229,618 from 54 companies across 707 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gelblum's costs compare to other neurologys in Aventura?
Dr. Gelblum's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gelblum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →